Ashish Juvekar Selected Research

Ashish Juvekar Research Topics

6	Neoplasms (Cancer) 12/2020 - 07/2008
3	Triple Negative Breast Neoplasms 01/2016 - 03/2011
3	Breast Neoplasms (Breast Cancer) 01/2016 - 03/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 10/2020
2	Cytokine Release Syndrome 12/2020 - 01/2020
1	Lymphoma (Lymphomas) 12/2020
1	B-Cell Leukemia (Leukemia, B Cell) 12/2020
1	Arthritis (Polyarthritis) 10/2020
1	Colitis 10/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020
1	COVID-19 01/2020
1	Leukemia 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 07/2008

3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2008
2	itacitinibIBA 12/2020 - 10/2020
2	CytokinesIBA 12/2020 - 01/2020
2	NVP-BKM120IBA 01/2016 - 11/2012
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2016 - 11/2012
1	Chimeric Antigen ReceptorsIBA 12/2020
1	INCB039110IBA 12/2020
1	ruxolitinibIBA 01/2020
1	VaccinesIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Janus KinasesIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	Adenosine Diphosphate (ADP)IBA 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	Buthionine SulfoximineIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Interleukin-8 (Interleukin 8)IBA 04/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2012
1	Mitogen-Activated Protein KinasesIBA 11/2012
1	olaparibIBA 11/2012
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2012
1	Estrogen ReceptorsIBA 03/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2011
1	ErbB Receptors (EGF Receptor)IBA 03/2011
1	Cre recombinaseIBA 03/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2011
1	NF-KappaB Inhibitor alphaIBA 07/2008
1	Proteasome InhibitorsIBA 07/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2008

2	Therapeutics 12/2020 - 11/2012
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Immunotherapy 12/2020
1	Cannula 10/2020